EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer

Yardley Denise A.; Weaver Robert; Melisko Michelle E.; Saleh Mansoor N.; Arena Francis P.; Forero Andres; Cigler Tessa; Stopeck Alison; Citrin Dennis; Oliff Ira; Bechhold Rebecca; Loutfi Randa; Garcia Agustin A.; Cruickshank Scott; Crowley Elizabeth; Green Jennifer; Hawthorne Thomas; Yellin Michael J.; Davis Thomas A.; Vahdat Linda T.

首页> 外文期刊>Journal of Clinical Oncology >EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer

【24h】

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer

机译：出现：随机期II研究在晚期糖蛋白NMB表达乳腺癌中的抗体 - 药物缀合物Glembatumumab Vedotin研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2015年第14期|共15页
作者
Yardley Denise A.; Weaver Robert; Melisko Michelle E.; Saleh Mansoor N.; Arena Francis P.; Forero Andres; Cigler Tessa; Stopeck Alison; Citrin Dennis; Oliff Ira; Bechhold Rebecca; Loutfi Randa; Garcia Agustin A.; Cruickshank Scott; Crowley Elizabeth; Green Jennifer; Hawthorne Thomas; Yellin Michael J.; Davis Thomas A.; Vahdat Linda T.;
展开▼
作者单位

Tennessee Oncol Sarah Cannon Res Inst Nashville TN USA;

Florida Canc Specialists Tampa FL USA;

Univ Calif San Francisco Helen Diller Family Comprehens Canc Ctr San Francisco CA 94143 USA;

Georgia Canc Specialists Sandy Springs GA USA;

New York Univ Langons Arena Oncol Lake Success NY USA;

Univ Alabama Birmingham Birmingham AL USA;

Weill Cornell Med Coll New York NY USA;

Univ Arizona Ctr Canc Tucson AZ USA;

Midwestern Reg Med Ctr Canc Treatment Ctr Amer Zion IL USA;

Orchard Healthcare Res Skokie IL USA;

Oncol Hematol Care Cincinnati OH USA;

Henry Ford Hlth Syst Detroit MI USA;

Univ So Calif Kenneth Norris Jr Comprehens Canc Ctr Los Angeles CA 90033 USA;

Scott Cruickshank &

Associates Santa Barbara CA USA;

Celldex Therapeut Hampton NJ USA;

Celldex Therapeut Hampton NJ USA;

Celldex Therapeut Hampton NJ USA;

Celldex Therapeut Hampton NJ USA;

Celldex Therapeut Hampton NJ USA;

Weill Cornell Med Coll New York NY USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer (vol 33, pg 1609, 2015) [J] . Yardley D. A., Weaver R., Melisko M. E. Journal of Clinical Oncology . 2015,第18期

机译：新兴：晚期药物糖蛋白NMB表达的乳腺癌中抗体-药物偶联物格伦巴单抗Vedotin的随机II期研究（第33卷，第1609页，2015年）
3. EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer (vol 33, pg 1609, 2015) [J] . Yardley D. A., Weaver R., Melisko M. E. Journal of Clinical Oncology . 2015,第18期

机译：出现：随机期II研究在晚期糖蛋白NMB表达乳腺癌中的抗体 - 药物缀合物Glembatumumab Vedotin研究（Vol 33，PG 1609,2015）
4. EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer [J] . Yardley Denise A., Weaver Robert, Melisko Michelle E., Journal of Clinical Oncology . 2015,第14期

机译：出现：随机期II研究在晚期糖蛋白NMB表达乳腺癌中的抗体 - 药物缀合物Glembatumumab Vedotin研究
5. Stilbene analogues as inhibitors of breast cancer Stem cells through P-glycoprotein efflux; A 3D quantitative structure-activity relationship study (Inhibitory activity of stilbenes analogues on breast cancer stem cells) [C] . Anushree Tripathi, Krishna Misra 2016 International Conference on Bioinformatics and Systems Biology . 2016

机译：Stilbene类似物通过P-糖蛋白外排作为乳腺癌干细胞的抑制剂； 3D定量结构-活性关系研究（Stilbenes类似物对乳腺癌干细胞的抑制活性）
6. Prospective Phase II Multicenter Registry of Ablation after Breast Lumpectomy Added to Extend (ABLATE) Intraoperative Margins in the Treatment of Breast Cancer [D] . Klimberg, V. Suzanne. 2017

机译：乳房肿块切除术后消融的前瞻性II期多中心消融术增加了扩大（ABLATE）术中切缘在治疗乳腺癌中的作用
7. Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma [O] . Patrick A. Ott, Omid Hamid, Anna C. Pavlick, -1

机译：晚期黑素瘤患者抗体-药物结合的格伦巴单抗Vedotin的I / II期研究
8. Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast [O] . Johanna Bendell, Suzanne Jones, A. N. Rose, 2014

机译：局部晚期或转移性乳腺癌患者抗体 - 药物偶联物glembatumumab vedotin的I / II期研究

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer

摘要

著录项

相似文献

相关主题

期刊订阅